LivaNova PLCLIVN
Price$74.70Intrinsic value$69.707% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $69.70median of 5 methods · middle span $54-$96based on filings through 30 Jun 2026
Market Price $74.70Price as of 1 Oct 2026
Margin of Safety -6.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 4.1% (near-term consensus, capped) · years 2–5: 11.8%/yr (balance of the path).10.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 611.5%Yr 711.2%Yr 810.9%Yr 910.6%Yr 1010.3%
11.8% → 10.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.5%Yr 128.8%Yr 138.1%Yr 147.4%Yr 156.6%Yr 165.9%Yr 175.2%Yr 184.5%Yr 193.7%Yr 203.0%
10.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 9.1%
Volatility vs market (adjusted beta)0.91

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetLivaNova PLCLIVNHealth Care
Valuation
P/E—
P/S2.9×
P/B3.3×
EV / Revenue2.8×
EV / EBITDA—
Profitability
Gross margin67.7%
Operating margin14.4%
Net margin12.8%
FCF margin10.1%
Returns
ROE14.2%
ROA7.1%
ROIC17.2%
Growth
Revenue growth (YoY)17.4%
5-yr fwd EPS growth10.3%
Financial strength
Debt / Equity0.22×
Current ratio1.45×
Altman Z-Score2.4
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.